IMMUNOLOGY2026
Meet GemPharmatech at IMMUNOLOGY2026™
GemPharmatech is excited to exhibit at IMMUNOLOGY2026™, the 109th Annual Meeting of the American Association of Immunologists (AAI), taking place April 16–18, 2026 in Boston, MA.
Visit us at Booth #1230 to connect with our scientific experts and explore our latest R&D innovations. Discover how our comprehensive portfolio of validated autoimmune models and one-stop efficacy evaluation platforms can accelerate your immunotherapy programs—from discovery through clinical translation.
Poster Presentations
We will present four posters, featuring topics ranging from autoimmune disease modeling to translational platforms for respiratory and gastrointestinal inflammation, including alopecia areata, C3 glomerulopathy, neutrophilic asthma, and inflammatory bowel disease.
Thursday, April 16, 2026
11:30 AM – 12:30 PM | Board 555
Development and Therapeutic Evaluation of a Uniform Lymph Node Cell Transfer Model of Alopecia Areata
02:30 PM – 03:30 PM | Board 402
Therapeutic Evaluation of a C3-Targeting Small Nucleic Acid Drug in a Spontaneous Humanized C3 Glomerulopathy Mouse Model
Friday, April 17, 2026
11:30 AM – 12:30 PM | Board 191
LPS-HDM-Induced Asthma Model: A Translational Platform for Neutrophilic Asthma and Glucocorticoid-Resistant Inflammation
Saturday, April 18, 2026
11:30 AM – 12:30 PM | Board 711
A Novel Mouse Colitis Model Recapitulating Human T Cell and Myeloid Cell Reconstitution to Support Drug Evaluation in Inflammatory Bowel Disease
Let’s Connect
Meet our scientific team on-site to discuss the latest advances in immunology and explore potential collaborations. Learn how GemPharmatech’s precision models and data-driven expertise can help you achieve your research goals.
Schedule a one-on-one meeting: sales@gempharmatech.com
Explore Our Autoimmune Disease Models
Discover our validated mouse models designed to advance autoimmune research. From genetically engineered and humanized strains to induced disease models, our platforms enable you to:
Uncover disease mechanisms
Evaluate therapeutic efficacy
Accelerate drug development across diverse autoimmune and inflammatory indications
On-Demand Webinar
Rethinking Asthma Preclinical Models: Matching Mouse Models to Drug Mechanism Across Asthma Phenotypes
Join Wen Zeng as he explores the limitations of traditional HDM-induced asthma models in the era of dupilumab. Gain insights into next-generation models that better capture asthma heterogeneity and enable more predictive preclinical evaluation.